Recce Pharmaceuticals Limited (ASX:RCE) Secures Approval for Phase 3 Clinical Trial
Recce Pharmaceuticals receives approval for a Phase 3 trial of RECCE® 327 in Indonesia for diabetic foot infections.
Recce Pharmaceuticals receives approval for a Phase 3 trial of RECCE® 327 in Indonesia for diabetic foot infections.
Odyssey Gold (ASX:ODY) reports successful diamond drilling, confirming gold mineralisation and extending the Highway Zone.
Venus Metals Corporation Limited (ASX:VMC) reports high-grade gold assays from Henderson Project, indicating strong exploration potential.
WA1 Resources Ltd announces positive results from niobium beneficiation testwork at the West Arunta Project.
Energy Resources of Australia announces leadership transitions with Brad Welsh moving to a consultancy role and David Pritchard-Davies as new CFO.
Platinum Asset Management (ASX:PTM) declares a special dividend and concludes discussions with Regal while pursuing a turnaround strategy.
AusQuest Limited (ASX:AQD) has commenced drilling at its Moora Project, targeting significant Ni-Cu-PGE mineralization.
GQG Partners (ASX:GQG) terminates CDI buyback due to uncertainties in US tax treatment affecting shareholder proceeds.
Tivan Limited’s Speewah Fluorite Project has been awarded Major Project Status, signifying its strategic importance and government support.
Elevate Uranium Limited (ASX:EL8) shares progress on exploration and upcoming U-pgrade™ demonstration plant in Namibia.